Molina Healthcare, Inc. (NYSE:MOH – Get Rating) has been given an average recommendation of “Hold” by the thirteen research firms that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $362.92.
→ The Biggest “Missing Ingredient” in the $7 Trillion EV Market (From Investing Trends)
A number of brokerages have recently issued reports on MOH. Bank of America raised Molina Healthcare from an “underperform” rating to a “neutral” rating and set a $388.00 price target on the stock in a research note on Tuesday, December 13th. Stephens reiterated an “equal weight” rating and set a $375.00 price objective on shares of Molina Healthcare in a research report on Thursday, February 9th. Truist Financial reduced their price objective on Molina Healthcare from $400.00 to $380.00 and set a “buy” rating on the stock in a research report on Friday, February 10th. Deutsche Bank Aktiengesellschaft lifted their price objective on Molina Healthcare from $315.00 to $355.00 and gave the stock a “hold” rating in a research report on Tuesday, November 1st. Finally, Barclays reduced their price objective on Molina Healthcare from $400.00 to $375.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 4th.
Insiders Place Their Bets
In other news, EVP Marc Russo sold 1,500 shares of the firm’s stock in a transaction on Monday, December 12th. The stock was sold at an average price of $351.17, for a total transaction of $526,755.00. Following the completion of the transaction, the executive vice president now directly owns 15,513 shares in the company, valued at $5,447,700.21. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, EVP Marc Russo sold 1,500 shares of the stock in a transaction on Monday, December 12th. The stock was sold at an average price of $351.17, for a total value of $526,755.00. Following the sale, the executive vice president now directly owns 15,513 shares in the company, valued at $5,447,700.21. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Dale B. Wolf sold 2,500 shares of the stock in a transaction on Wednesday, December 7th. The shares were sold at an average price of $339.50, for a total value of $848,750.00. Following the completion of the sale, the director now owns 15,491 shares in the company, valued at $5,259,194.50. The disclosure for this sale can be found here. 1.49% of the stock is owned by insiders.
Hedge Funds Weigh In On Molina Healthcare
Large investors have recently bought and sold shares of the business. Quadrant Capital Group LLC boosted its stake in Molina Healthcare by 10.9% in the second quarter. Quadrant Capital Group LLC now owns 316 shares of the company’s stock valued at $88,000 after acquiring an additional 31 shares in the last quarter. JGP Global Gestao de Recursos Ltda. raised its position in Molina Healthcare by 3.8% in the 3rd quarter. JGP Global Gestao de Recursos Ltda. now owns 847 shares of the company’s stock valued at $279,000 after purchasing an additional 31 shares during the last quarter. KBC Group NV raised its position in Molina Healthcare by 0.5% in the 3rd quarter. KBC Group NV now owns 6,334 shares of the company’s stock valued at $2,089,000 after purchasing an additional 33 shares during the last quarter. Captrust Financial Advisors raised its position in Molina Healthcare by 0.5% in the 2nd quarter. Captrust Financial Advisors now owns 6,315 shares of the company’s stock valued at $1,766,000 after purchasing an additional 33 shares during the last quarter. Finally, Lmcg Investments LLC raised its position in Molina Healthcare by 1.4% in the 3rd quarter. Lmcg Investments LLC now owns 2,523 shares of the company’s stock valued at $832,000 after purchasing an additional 35 shares during the last quarter. Hedge funds and other institutional investors own 94.25% of the company’s stock.
Molina Healthcare Stock Up 1.1 %
Shares of NYSE MOH opened at $296.07 on Monday. Molina Healthcare has a 52-week low of $249.78 and a 52-week high of $374.00. The company’s 50-day simple moving average is $312.31 and its 200-day simple moving average is $328.62. The company has a quick ratio of 1.45, a current ratio of 1.47 and a debt-to-equity ratio of 0.81. The firm has a market cap of $17.14 billion, a price-to-earnings ratio of 21.85, a price-to-earnings-growth ratio of 0.78 and a beta of 0.69.
Molina Healthcare (NYSE:MOH – Get Rating) last issued its quarterly earnings results on Wednesday, February 8th. The company reported $4.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.06 by $0.04. The firm had revenue of $8.22 billion for the quarter, compared to analyst estimates of $7.87 billion. Molina Healthcare had a return on equity of 36.05% and a net margin of 2.48%. The business’s revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.88 earnings per share. Equities analysts predict that Molina Healthcare will post 19.45 EPS for the current fiscal year.
About Molina Healthcare
Molina Healthcare, Inc engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Molina Healthcare, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Molina Healthcare wasn’t on the list.
While Molina Healthcare currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here